%!TEX TS-program = xelatex
%!TEX encoding = UTF-8 Unicode
% Awesome CV LaTeX Template for CV/Resume
%
% This template has been downloaded from:
% https://github.com/posquit0/Awesome-CV
%
% Author:
% Claud D. Park <posquit0.bj@gmail.com>
% http://www.posquit0.com
%
%
% Adapted to be an Rmarkdown template by Mitchell O'Hara-Wild
% 23 November 2018
%
% Template license:
% CC BY-SA 4.0 (https://creativecommons.org/licenses/by-sa/4.0/)
%
%-------------------------------------------------------------------------------
% CONFIGURATIONS
%-------------------------------------------------------------------------------
% A4 paper size by default, use 'letterpaper' for US letter
\documentclass[11pt,a4paper,]{awesome-cv}

% Configure page margins with geometry
\usepackage{geometry}
\geometry{left=1.4cm, top=.8cm, right=1.4cm, bottom=1.8cm, footskip=.5cm}


% Specify the location of the included fonts
\fontdir[fonts/]

% Color for highlights
% Awesome Colors: awesome-emerald, awesome-skyblue, awesome-red, awesome-pink, awesome-orange
%                 awesome-nephritis, awesome-concrete, awesome-darknight

\colorlet{awesome}{awesome-red}

% Colors for text
% Uncomment if you would like to specify your own color
% \definecolor{darktext}{HTML}{414141}
% \definecolor{text}{HTML}{333333}
% \definecolor{graytext}{HTML}{5D5D5D}
% \definecolor{lighttext}{HTML}{999999}

% Set false if you don't want to highlight section with awesome color
\setbool{acvSectionColorHighlight}{true}

% If you would like to change the social information separator from a pipe (|) to something else
\renewcommand{\acvHeaderSocialSep}{\quad\textbar\quad}

\def\endfirstpage{\newpage}

%-------------------------------------------------------------------------------
%	PERSONAL INFORMATION
%	Comment any of the lines below if they are not required
%-------------------------------------------------------------------------------
% Available options: circle|rectangle,edge/noedge,left/right

\name{Sebastian}{Bate}

\position{Medical Statistician}

\mobile{07985 357150}
\email{\href{mailto:sebastiangbate@gmail.com}{\nolinkurl{sebastiangbate@gmail.com}}}
\orcid{0000-0002-2218-503X}
\github{sgbstats}
\linkedin{sebastianbate}

% \gitlab{gitlab-id}
% \stackoverflow{SO-id}{SO-name}
% \skype{skype-id}
% \reddit{reddit-id}


\usepackage{booktabs}

\providecommand{\tightlist}{%
	\setlength{\itemsep}{0pt}\setlength{\parskip}{0pt}}

%------------------------------------------------------------------------------



% Pandoc CSL macros
\newlength{\cslhangindent}
\setlength{\cslhangindent}{1.5em}
\newlength{\csllabelwidth}
\setlength{\csllabelwidth}{2em}
\newenvironment{CSLReferences}[2] % #1 hanging-ident, #2 entry spacing
 {% don't indent paragraphs
  \setlength{\parindent}{0pt}
  % turn on hanging indent if param 1 is 1
  \ifodd #1 \everypar{\setlength{\hangindent}{\cslhangindent}}\ignorespaces\fi
  % set entry spacing
  \ifnum #2 > 0
  \setlength{\parskip}{#2\baselineskip}
  \fi
 }%
 {}
\usepackage{calc}
\newcommand{\CSLBlock}[1]{#1\hfill\break}
\newcommand{\CSLLeftMargin}[1]{\parbox[t]{\csllabelwidth}{\honortitlestyle{#1}}}
\newcommand{\CSLRightInline}[1]{\parbox[t]{\linewidth - \csllabelwidth}{\honordatestyle{#1}}}
\newcommand{\CSLIndent}[1]{\hspace{\cslhangindent}#1}

\begin{document}

% Print the header with above personal informations
% Give optional argument to change alignment(C: center, L: left, R: right)
\makecvheader

% Print the footer with 3 arguments(<left>, <center>, <right>)
% Leave any of these blank if they are not needed
% 2019-02-14 Chris Umphlett - add flexibility to the document name in footer, rather than have it be static Curriculum Vitae
\makecvfooter
  {September 2025}
    {Sebastian Bate~~~·~~~Curriculum Vitae}
  {\thepage~ of \pageref{LastPage}~}


%-------------------------------------------------------------------------------
%	CV/RESUME CONTENT
%	Each section is imported separately, open each file in turn to modify content
%------------------------------------------------------------------------------



\section{Experience}\label{experience}

\begin{cventries}
    \cventry{Junior Medical Statistician}{Manchester University NHS Foundation Trust}{Mar 2021-}{}{\begin{cvitems}
\item I have been involved in multiple studies and lead on statistical design and analysis from concept through to dissemination.
\item I support all levels of researchers from undergraduate and postgraduate students, through to clinical academics and consultants.
\item I have contributed to sucessful grant applications as a co-investigator and lead statistician (NIHR152516)
\item I have been responsible for reviewing the design, statistical accuracy and overall viability of Trust-sponsored research protocols prior to ethics submission in collaboration with senior statisticians.
\item I have presented my research at conferences both to technical and clinical audiences [NIHR Statistics Group Conference, 2023 (best e-poster); NHS R Community Conference, 2022; Translation Manchester, 2022 (People's Choice award)], NIHR Statistics Group Conference, 2024 [3rd place]
\item I have multiple collaborations with clinicians across the whole of MFT, The University of Manchester, and other trusts.
\item I have given multiple talks on statistics for critical appraisal across The Trust to the prestigious Specialist Foundation Program, junior doctors and level 7+ clinical practitioners.
\item I have written teaching materials for improving statistical literacy among clinicians.
\item I have given guest lectures to undergraduates and apprentices on data literacy at Manchester Metropolitan University (Digital Marketer Degree Apprenticeship, and UG Marketing, Business & Marketing and Advertising & Brand Communications courses).
\end{cvitems}}
    \cventry{Statistician}{IQVIA}{Sep 2019-Feb 2021}{}{\begin{cvitems}
\item I worked with senior biostatistics staff on the evaluation, interpretation, and reporting of study results, including writing the analysis data reviewer’s guide for one study.
\item I quality controlled regulatory documents including CSRs, summaries of clinical efficacy and safety, prescribing information, and FDA briefing documents for large pivotal studies.
\item I assisted in developing study analysis plans, including sample size calculations and mock TFLs across multiple studies.
\item I gained experience in applying the principles in ICH E6 (GCP), E9 (Statistics), E9R1 (Estimands).
\end{cvitems}}
\end{cventries}

\section{Education}\label{education}

\begin{cventries}
    \cventry{MMath Mathematics and Statisitcs, First Class (Hons.)}{University of Manchester}{2015-19}{}{}\vspace{-4.0mm}
\end{cventries}

\section{Selected Peer Reviewed
Publications}\label{selected-peer-reviewed-publications}

\phantomsection\label{bibliography}
\bibitem[\citeproctext]{ref-bate_predictors_2025}
\CSLLeftMargin{1. }%
\CSLRightInline{Bate S, Fortescue R, Fullwood C, et al. Predictors of
treatment REsponse to inhaled corticosteroids (ICS) in Chronic
Obstructive pulmonary disease: Randomised controlled trials individual
participant Data re-Evaluation--protocol of the ICS-RECODE individual
participant data meta-analysis. \emph{BMJ Open}. 2025;15(3):e095541.
doi:\href{https://doi.org/10.1136/bmjopen-2024-095541}{10.1136/bmjopen-2024-095541}}

\bibitem[\citeproctext]{ref-flame}
\CSLLeftMargin{2. }%
\CSLRightInline{Mathioudakis AG, Bate S, Sivapalan P, Jensen J-US, Singh
D, Vestbo J. Rethinking blood eosinophils for assessing inhaled
corticosteroids response in COPD. \emph{CHEST}. 2024;166(5):987-997.
doi:\href{https://doi.org/10.1016/j.chest.2024.06.3790}{10.1016/j.chest.2024.06.3790}}

\bibitem[\citeproctext]{ref-bate2024external}
\CSLLeftMargin{3. }%
\CSLRightInline{Bate S, Stokes V, Greenlee H, et al. External validation
of prognostic models in critical care: A cautionary tale from COVID-19
pneumonitis. \emph{Critical Care Explorations}. 2024;6(4):e1067.
doi:\href{https://doi.org/10.1097/CCE.0000000000001067}{10.1097/CCE.0000000000001067}}

\bibitem[\citeproctext]{ref-batek360}
\CSLLeftMargin{4. }%
\CSLRightInline{Bate S. Will the ANCA kidney risk score become the gold
standard for prognostication in ANCA-associated GN? \emph{Kidney360}.
2024;5(6):789-790.
doi:\href{https://doi.org/10.34067/KID.0000000000000455}{10.34067/KID.0000000000000455}}

\bibitem[\citeproctext]{ref-akris}
\CSLLeftMargin{5. }%
\CSLRightInline{Bate S, McGovern D, Costigliolo F, et al. The improved
kidney risk score in ANCA-associated vasculitis for clinical practice
and trials. \emph{Journal of the American Society of Nephrology}.
2023;35(3):335-346.
doi:\href{https://doi.org/10.1681/ASN.0000000000000274}{10.1681/ASN.0000000000000274}}

\bibitem[\citeproctext]{ref-gbm}
\CSLLeftMargin{6. }%
\CSLRightInline{Floyd L, Bate S, Kafagi A, et al. Risk stratification to
predict renal survival in anti-GBM disease. \emph{Journal of the
American Society of Nephrology}. 2023;34(3):505-514.
doi:\href{https://doi.org/10.1681/asn.2022050581}{10.1681/asn.2022050581}}

\bibitem[\citeproctext]{ref-FI}
\CSLLeftMargin{7. }%
\CSLRightInline{Vasant DH, Nigam GB, Bate S, Hamdy S, Limdi JK. The
prevalence and burden of rome IV faecal incontinence in ulcerative
colitis: A cross-sectional study. \emph{Alimentary Pharmacology \&
Therapeutics}. 2023;58(1):26-34.
doi:\href{https://doi.org/10.1111/apt.17502}{10.1111/apt.17502}}

\bibitem[\citeproctext]{ref-pla2r}
\CSLLeftMargin{8. }%
\CSLRightInline{Ragy O, Bate S, Bukhari S, et al. PLA2R antibody does
not outperform conventional clinical markers in predicting outcomes in
membranous nephropathy. \emph{Kidney International Reports}.
2023;8(8):1605-1615.
doi:\href{https://doi.org/10.1016/j.ekir.2023.05.019}{10.1016/j.ekir.2023.05.019}}

\bibitem[\citeproctext]{ref-CSOM}
\CSLLeftMargin{9. }%
\CSLRightInline{Heward E, Saeed H, Bate S, et al. Risk factors
associated with the development of chronic suppurative otitis media in
children: Systematic review and meta-analysis. \emph{Clinical
Otolaryngology}. 2023;(1):62-73.
doi:\href{https://doi.org/10.1111/coa.14102}{10.1111/coa.14102}}

\bibitem[\citeproctext]{ref-oremule2023mobile}
\CSLLeftMargin{10. }%
\CSLRightInline{Oremule B, Abbas J, Saunders G, et al. Mobile audiometry
for hearing threshold assessment: A systematic review and meta-analysis.
\emph{Clinical Otolaryngology}. 2023;(1):74-86.
doi:\href{https://doi.org/10.1111/coa.14107}{10.1111/coa.14107}}

\bibitem[\citeproctext]{ref-cpap}
\CSLLeftMargin{11. }%
\CSLRightInline{Stokes V, Goh KY, Whiting G, et al. External validation
of a prediction model for CPAP failure in COVID-19 patients with severe
pneumonitis. \emph{Critical Care}. 2022;26(1):293.
doi:\href{https://doi.org/10.1186/s13054-022-04144-4}{10.1186/s13054-022-04144-4}}

\section{Languages \& Certifications}\label{languages-certifications}

\begin{itemize}
\tightlist
\item
  R, inc. Tidyverse (Expert)
\item
  SPSS (Proficient)
\item
  SAS (Was proficient, now rusty)
\item
  NIHR Good Clinical/Statistical Practice
\item
  Python (Can debug something but don't like writing it)
\item
  Quarto
\end{itemize}

\section{Areas of interest}\label{areas-of-interest}

\begin{itemize}
\tightlist
\item
  Prognostic modeling
\item
  Meta-analysis
\end{itemize}

\section{Personal}\label{personal}

\begin{itemize}
\tightlist
\item
  I have run a 3:03:45 marathon
\item
  I have an Erdos number of 6
\item
  This CV was written in RMarkdown using \emph{\{vitae\}}
\end{itemize}

\section{Experience}\label{experience-1}

\begin{cventries}
    \cventry{Junior Medical Statistician}{Manchester University NHS Foundation Trust}{Mar 2021-}{}{\begin{cvitems}
\item I have been involved in multiple studies and lead on statistical design and analysis from concept through to dissemination.
\item I support all levels of researchers from undergraduate and postgraduate students, through to clinical academics and consultants.
\item I have contributed to sucessful grant applications as a co-investigator and lead statistician (NIHR152516)
\item I have been responsible for reviewing the design, statistical accuracy and overall viability of Trust-sponsored research protocols prior to ethics submission in collaboration with senior statisticians.
\item I have presented my research at conferences both to technical and clinical audiences [NIHR Statistics Group Conference, 2023 (best e-poster); NHS R Community Conference, 2022; Translation Manchester, 2022 (People's Choice award)], NIHR Statistics Group Conference, 2024 [3rd place]
\item I have multiple collaborations with clinicians across the whole of MFT, The University of Manchester, and other trusts.
\item I have given multiple talks on statistics for critical appraisal across The Trust to the prestigious Specialist Foundation Program, junior doctors and level 7+ clinical practitioners.
\item I have written teaching materials for improving statistical literacy among clinicians.
\item I have given guest lectures to undergraduates and apprentices on data literacy at Manchester Metropolitan University (Digital Marketer Degree Apprenticeship, and UG Marketing, Business & Marketing and Advertising & Brand Communications courses).
\end{cvitems}}
    \cventry{Statistician}{IQVIA}{Sep 2019-Feb 2021}{}{\begin{cvitems}
\item I worked with senior biostatistics staff on the evaluation, interpretation, and reporting of study results, including writing the analysis data reviewer’s guide for one study.
\item I quality controlled regulatory documents including CSRs, summaries of clinical efficacy and safety, prescribing information, and FDA briefing documents for large pivotal studies.
\item I assisted in developing study analysis plans, including sample size calculations and mock TFLs across multiple studies.
\item I gained experience in applying the principles in ICH E6 (GCP), E9 (Statistics), E9R1 (Estimands).
\end{cvitems}}
\end{cventries}

\section{Education}\label{education-1}

\begin{cventries}
    \cventry{MMath Mathematics and Statisitcs, First Class (Hons.)}{University of Manchester}{2015-19}{}{}\vspace{-4.0mm}
\end{cventries}

\section{Selected Peer Reviewed
Publications}\label{selected-peer-reviewed-publications-1}

\phantomsection\label{bibliography}
\bibitem[\citeproctext]{ref-bate_predictors_2025}
\CSLLeftMargin{1. }%
\CSLRightInline{Bate S, Fortescue R, Fullwood C, et al. Predictors of
treatment REsponse to inhaled corticosteroids (ICS) in Chronic
Obstructive pulmonary disease: Randomised controlled trials individual
participant Data re-Evaluation--protocol of the ICS-RECODE individual
participant data meta-analysis. \emph{BMJ Open}. 2025;15(3):e095541.
doi:\href{https://doi.org/10.1136/bmjopen-2024-095541}{10.1136/bmjopen-2024-095541}}

\bibitem[\citeproctext]{ref-flame}
\CSLLeftMargin{2. }%
\CSLRightInline{Mathioudakis AG, Bate S, Sivapalan P, Jensen J-US, Singh
D, Vestbo J. Rethinking blood eosinophils for assessing inhaled
corticosteroids response in COPD. \emph{CHEST}. 2024;166(5):987-997.
doi:\href{https://doi.org/10.1016/j.chest.2024.06.3790}{10.1016/j.chest.2024.06.3790}}

\bibitem[\citeproctext]{ref-bate2024external}
\CSLLeftMargin{3. }%
\CSLRightInline{Bate S, Stokes V, Greenlee H, et al. External validation
of prognostic models in critical care: A cautionary tale from COVID-19
pneumonitis. \emph{Critical Care Explorations}. 2024;6(4):e1067.
doi:\href{https://doi.org/10.1097/CCE.0000000000001067}{10.1097/CCE.0000000000001067}}

\bibitem[\citeproctext]{ref-batek360}
\CSLLeftMargin{4. }%
\CSLRightInline{Bate S. Will the ANCA kidney risk score become the gold
standard for prognostication in ANCA-associated GN? \emph{Kidney360}.
2024;5(6):789-790.
doi:\href{https://doi.org/10.34067/KID.0000000000000455}{10.34067/KID.0000000000000455}}

\bibitem[\citeproctext]{ref-akris}
\CSLLeftMargin{5. }%
\CSLRightInline{Bate S, McGovern D, Costigliolo F, et al. The improved
kidney risk score in ANCA-associated vasculitis for clinical practice
and trials. \emph{Journal of the American Society of Nephrology}.
2023;35(3):335-346.
doi:\href{https://doi.org/10.1681/ASN.0000000000000274}{10.1681/ASN.0000000000000274}}

\bibitem[\citeproctext]{ref-gbm}
\CSLLeftMargin{6. }%
\CSLRightInline{Floyd L, Bate S, Kafagi A, et al. Risk stratification to
predict renal survival in anti-GBM disease. \emph{Journal of the
American Society of Nephrology}. 2023;34(3):505-514.
doi:\href{https://doi.org/10.1681/asn.2022050581}{10.1681/asn.2022050581}}

\bibitem[\citeproctext]{ref-FI}
\CSLLeftMargin{7. }%
\CSLRightInline{Vasant DH, Nigam GB, Bate S, Hamdy S, Limdi JK. The
prevalence and burden of rome IV faecal incontinence in ulcerative
colitis: A cross-sectional study. \emph{Alimentary Pharmacology \&
Therapeutics}. 2023;58(1):26-34.
doi:\href{https://doi.org/10.1111/apt.17502}{10.1111/apt.17502}}

\bibitem[\citeproctext]{ref-pla2r}
\CSLLeftMargin{8. }%
\CSLRightInline{Ragy O, Bate S, Bukhari S, et al. PLA2R antibody does
not outperform conventional clinical markers in predicting outcomes in
membranous nephropathy. \emph{Kidney International Reports}.
2023;8(8):1605-1615.
doi:\href{https://doi.org/10.1016/j.ekir.2023.05.019}{10.1016/j.ekir.2023.05.019}}

\bibitem[\citeproctext]{ref-CSOM}
\CSLLeftMargin{9. }%
\CSLRightInline{Heward E, Saeed H, Bate S, et al. Risk factors
associated with the development of chronic suppurative otitis media in
children: Systematic review and meta-analysis. \emph{Clinical
Otolaryngology}. 2023;(1):62-73.
doi:\href{https://doi.org/10.1111/coa.14102}{10.1111/coa.14102}}

\bibitem[\citeproctext]{ref-oremule2023mobile}
\CSLLeftMargin{10. }%
\CSLRightInline{Oremule B, Abbas J, Saunders G, et al. Mobile audiometry
for hearing threshold assessment: A systematic review and meta-analysis.
\emph{Clinical Otolaryngology}. 2023;(1):74-86.
doi:\href{https://doi.org/10.1111/coa.14107}{10.1111/coa.14107}}

\bibitem[\citeproctext]{ref-cpap}
\CSLLeftMargin{11. }%
\CSLRightInline{Stokes V, Goh KY, Whiting G, et al. External validation
of a prediction model for CPAP failure in COVID-19 patients with severe
pneumonitis. \emph{Critical Care}. 2022;26(1):293.
doi:\href{https://doi.org/10.1186/s13054-022-04144-4}{10.1186/s13054-022-04144-4}}

\section{Languages \& Certifications}\label{languages-certifications-1}

\begin{itemize}
\tightlist
\item
  R, inc. Tidyverse (Expert)
\item
  SPSS (Proficient)
\item
  SAS (Was proficient, now rusty)
\item
  NIHR Good Clinical/Statistical Practice
\item
  Python (Can debug something but don't like writing it)
\item
  Quarto
\end{itemize}

\section{Areas of interest}\label{areas-of-interest-1}

\begin{itemize}
\tightlist
\item
  Prognostic modeling
\item
  Meta-analysis
\end{itemize}

\section{Personal}\label{personal-1}

\begin{itemize}
\tightlist
\item
  I have run a 3:03:45 marathon
\item
  I have an Erdos number of 6
\item
  This CV was written in RMarkdown using \emph{\{vitae\}}
\end{itemize}


\label{LastPage}~
\end{document}
